8-K: Lifeloc to Present SpinDetect Update at Conference

Lifeloc Technologies will present an update on its SpinDetect drug analyzer and current operations at the Emerging Growth Conference on September 25, 2025.

Summary

• Lifeloc Technologies, Inc. (OTC: LCTC) will present at the Emerging Growth Conference on Thursday, September 25, 2025, at 2:20 PM Eastern Daylight Time.
• Dr. Wayne Willkomm, Lifeloc's Chief Executive Officer, will provide an overview of current operations.
• Dr. Willkomm will share an update on the SpinDetect centrifugal drug analyzer, the company's next-generation analyzer currently under development.
• SpinDetect is described as a compact, microfluidic-based drug screening platform designed to meet global demand for fast, portable drug testing solutions.
• The presentation will be a live, interactive virtual event, followed by a Q&A session.
• A recording of the webcast will be available after the event on the Emerging Growth website and YouTube channel.

Sentiment

Score: 6

Explanation: The announcement is moderately positive, highlighting ongoing product development and investor outreach, but lacks specific financial or operational milestones that would significantly alter sentiment.

Positives

• The company is actively developing a next-generation drug analyzer, SpinDetect, addressing a growing market need for fast, portable drug testing.
• Participation in the Emerging Growth Conference provides a platform to communicate company updates and product development to a broader investor audience.
• The event includes a Q&A session, allowing for direct engagement with potential investors and stakeholders.

Risks

• Forward-looking statements in the press release involve substantial risks and uncertainties that may cause actual results to differ materially from those indicated.

Future Outlook

The company is focused on the development of its SpinDetect centrifugal drug analyzer, a next-generation platform aimed at meeting the growing global demand for fast, portable drug testing solutions. Management will provide an update on this development and current operations.

Management Comments

• Dr. Wayne Willkomm, Lifeloc's CEO, will provide an overview of current operations and an update on the SpinDetect centrifugal drug analyzer.

Industry Context

The development of the SpinDetect centrifugal drug analyzer aligns with a broader industry trend towards compact, rapid, and portable drug screening solutions, driven by increasing global demand in various sectors including workplace, law enforcement, and corrections.

Stakeholder Impact

• Shareholders and potential investors will receive an update on company operations and product development, potentially influencing investment decisions.
• Customers in workplace, law enforcement, and corrections sectors may anticipate the release of the SpinDetect analyzer for their drug testing needs.

Next Steps

• Lifeloc Technologies will present at the Emerging Growth Conference on September 25, 2025.
• A recording of the webcast will be made available after the event on the Emerging Growth website and YouTube channel, with a direct link to be shared by Lifeloc.

Key Dates

Recommendation

The filing is a routine announcement of a conference presentation and a brief update on a product under development. It does not contain new financial results, significant strategic shifts, or other material information that would warrant a change in investment posture. Investors should hold their positions pending more substantive updates.

Keywords

Lifeloc Technologies, LCTC, SpinDetect, drug analyzer, breath alcohol testers, Emerging Growth Conference, drug testing solutions, medical devices, OTC